85 related articles for article (PubMed ID: 10189772)
21. Breast cancer patients' attitudes toward clinical trials in the radiation oncology clinic versus those searching for trial information on the Internet.
Dolinsky CM; Wei SJ; Hampshire MK; Metz JM
Breast J; 2006; 12(4):324-30. PubMed ID: 16848841
[TBL] [Abstract][Full Text] [Related]
22. Patient willingness to participate in a clinical trial with preimplantation genetic diagnosis.
Shahine LK; Kuppermann M; Davis G; Creasman J; Cedars MI
Fertil Steril; 2008 Apr; 89(4):879-84. PubMed ID: 17980367
[TBL] [Abstract][Full Text] [Related]
23. The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trials.
Zhang J; Zhang H; Yu C; Li J; Jiang Y
Contemp Clin Trials; 2011 Sep; 32(5):649-53. PubMed ID: 21570486
[TBL] [Abstract][Full Text] [Related]
24. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
25. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
[TBL] [Abstract][Full Text] [Related]
26. Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation.
Solomon MJ; Pager CK; Young JM; Roberts R; Butow P
Surgery; 2003 Jun; 133(6):608-13. PubMed ID: 12796726
[TBL] [Abstract][Full Text] [Related]
27. Participation of pregnant women in clinical trials: will they participate and why?
Rodger MA; Makropoulos D; Walker M; Keely E; Karovitch A; Wells PS
Am J Perinatol; 2003 Feb; 20(2):69-76. PubMed ID: 12660911
[TBL] [Abstract][Full Text] [Related]
28. The 'number needed to sample' in primary care research. Comparison of two primary care sampling frames for chronic back pain.
Smith BH; Hannaford PC; Elliott AM; Smith WC; Chambers WA
Fam Pract; 2005 Apr; 22(2):205-14. PubMed ID: 15722397
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the impact of a patient clinical trials handbook among pharmacy students.
Graham AC; Raisch DW; Fye CL; Sather MR
Clin Ther; 2005 Feb; 27(2):238-45. PubMed ID: 15811487
[TBL] [Abstract][Full Text] [Related]
30. [An index of understanding randomised clinical trials in oncology].
Leroy T; Christophe V; Penel N; Antoine P; Vanlemmens L; Reich M; Clisant S
Bull Cancer; 2009 Jun; 96(6):741-50. PubMed ID: 19467958
[TBL] [Abstract][Full Text] [Related]
31. [Consent to enrollment in randomized clinical trials].
Yuasa H; Yoda T; Kawai T; Kakudo K; Sugisaki M; Hinoshita M; Jinde T; Hachiya Y; Sugiura M; Kurita K
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1459-64. PubMed ID: 10500534
[TBL] [Abstract][Full Text] [Related]
32. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision.
Wright JR; Whelan TJ; Schiff S; Dubois S; Crooks D; Haines PT; DeRosa D; Roberts RS; Gafni A; Pritchard K; Levine MN
J Clin Oncol; 2004 Nov; 22(21):4312-8. PubMed ID: 15514372
[TBL] [Abstract][Full Text] [Related]
33. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy.
Jenkins V; Fallowfield L
Br J Cancer; 2000 Jun; 82(11):1783-8. PubMed ID: 10839291
[TBL] [Abstract][Full Text] [Related]
34. A clinical development paradigm for cancer vaccines and related biologics.
Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
[TBL] [Abstract][Full Text] [Related]
35. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
36. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
37. Cancer screening knowledge, attitudes, and behaviors among culturally Deaf adults: implications for informed decision making.
Orsi JM; Margellos-Anast H; Perlman TS; Giloth BE; Whitman S
Cancer Detect Prev; 2007; 31(6):474-9. PubMed ID: 18061367
[TBL] [Abstract][Full Text] [Related]
38. Survey of the impact of randomised clinical trials on surgical practice in France. French Associations for Research in Surgery (AURC and ACAPEM). Association Universitaire de Recherche en Chirurgie. Association des Chirurgiens de l'Assistance Publique pour l'Evaluation Médicale.
Millat B; Fingerhut A; Flamant Y; Hay JM; Fagniez PL; Farah A; Duron JJ; Courchevel JM
Eur J Surg; 1999 Feb; 165(2):87-94. PubMed ID: 10192564
[TBL] [Abstract][Full Text] [Related]
39. The impact of consenter characteristics and experience on patient interest in clinical research.
Rasco DW; Xie Y; Yan J; Sayne JR; Skinner CS; Dowell JE; Gerber DE
Oncologist; 2009 May; 14(5):468-75. PubMed ID: 19401521
[TBL] [Abstract][Full Text] [Related]
40. A descriptive study comparing health attitudes of urban and rural oncology patients.
Howat A; Veitch C; Cairns W
Rural Remote Health; 2006; 6(4):563. PubMed ID: 17017848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
